ACRIVON THERAPEUTICS INC

Ticker: ACRV CUSIP: 004890109 Class: Common Stock

CITADEL ADVISORS LLC's Holding History (CIK: 0001423053)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 1,641,884 Value ($000) $3,957 Avg Close $2.17 Range $1.69 - $2.73
Q3 2025
Shares 1,541,326 Value ($000) $2,790 Avg Close $1.41 Range $1.15 - $2.67
Q2 2025
Shares 1,895,519 Value ($000) $2,256 Avg Close $1.37 Range $1.05 - $2.19
Q1 2025
Shares 1,895,519 Value ($000) $3,848 Avg Close $5.38 Range $2.02 - $8.00
Q4 2024
Shares 2,119,646 Value ($000) $12,760 Avg Close $7.27 Range $5.40 - $8.74
Q3 2024
Shares 2,140,628 Value ($000) $14,984 Avg Close $7.88 Range $5.74 - $10.16
Q2 2024
Shares 2,119,646 Value ($000) $12,294 Avg Close $8.05 Range $5.50 - $11.90
Q1 2024
Shares 1,680,027 Value ($000) $12,012 Avg Close $4.64 Range $3.19 - $7.31
Q4 2023
Shares 1,649,659 Value ($000) $8,116 Avg Close $5.28 Range $3.41 - $9.40
Q3 2023
Shares 1,650,457 Value ($000) $15,778 Avg Close $11.55 Range $8.81 - $13.50
Q2 2023
Shares 1,649,646 Value ($000) $21,379 Avg Close $12.10 Range $8.06 - $14.30
Q1 2023
Shares 1,641,022 Value ($000) $20,148 Avg Close $16.79 Range $11.25 - $25.47
Q4 2022
Shares 1,634,104 Value ($000) $18,211 Avg Close $12.69 Range $10.90 - $20.70